Page last updated: 2024-10-21

n-(3-(aminomethyl)benzyl)acetamidine and Brain Neoplasms

n-(3-(aminomethyl)benzyl)acetamidine has been researched along with Brain Neoplasms in 1 studies

N-(3-(aminomethyl)benzyl)acetamidine: structure in first source
N-[3-(aminomethyl)benzyl]acetamidine : An aralkylamine that is Nbenzylacetamidine substituted at position 3 on the benzene ring by an aminomethyl group. An inhibitor of nitric oxide synthase.

Brain Neoplasms: Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Palumbo, P1
Lombardi, F1
Augello, FR1
Giusti, I1
Luzzi, S1
Dolo, V1
Cifone, MG1
Cinque, B1

Other Studies

1 other study available for n-(3-(aminomethyl)benzyl)acetamidine and Brain Neoplasms

ArticleYear
NOS2 inhibitor 1400W Induces Autophagic Flux and Influences Extracellular Vesicle Profile in Human Glioblastoma U87MG Cell Line.
    International journal of molecular sciences, 2019, Jun-20, Volume: 20, Issue:12

    Topics: Amidines; Autophagy; Benzylamines; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Enzyme Inh

2019